These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20067594)

  • 21. Complement evasion by Borrelia burgdorferi: it takes three to tango.
    de Taeye SW; Kreuk L; van Dam AP; Hovius JW; Schuijt TJ
    Trends Parasitol; 2013 Mar; 29(3):119-28. PubMed ID: 23298533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.
    Uhde M; Ajamian M; Li X; Wormser GP; Marques A; Alaedini A
    Clin Infect Dis; 2016 Dec; 63(11):1399-1404. PubMed ID: 27585799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about their aetiology.
    Markowicz M; Kivaranovic D; Stanek G
    Clin Microbiol Infect; 2015 Dec; 21(12):1098-103. PubMed ID: 26321669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
    Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
    FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping human risk of infection with Borrelia burgdorferi sensu lato, the agent of Lyme borreliosis, in a periurban forest in France.
    Vourc'h G; Abrial D; Bord S; Jacquot M; Masséglia S; Poux V; Pisanu B; Bailly X; Chapuis JL
    Ticks Tick Borne Dis; 2016 Jul; 7(5):644-652. PubMed ID: 26897396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis.
    Pachner AR; Cadavid D; Shu G; Dail D; Pachner S; Hodzic E; Barthold SW
    Ann Neurol; 2001 Sep; 50(3):330-8. PubMed ID: 11558789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
    Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
    Infection; 1996; 24(1):9-16. PubMed ID: 8852456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ménage à trois: Borrelia, dendritic cells, and tick saliva interactions.
    Mason LM; Veerman CC; Geijtenbeek TB; Hovius JW
    Trends Parasitol; 2014 Feb; 30(2):95-103. PubMed ID: 24388562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Models of Cutaneous Inflammation.
    Bernard Q; Jaulhac B; Boulanger N
    Methods Mol Biol; 2018; 1690():319-327. PubMed ID: 29032555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyme disease.
    Coyle PK
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):479-87. PubMed ID: 12359100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borreliosis: recent research, diagnosis, and management.
    Hytönen J; Hartiala P; Oksi J; Viljanen MK
    Scand J Rheumatol; 2008; 37(3):161-72. PubMed ID: 18465449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study.
    Pritt BS; Mead PS; Johnson DKH; Neitzel DF; Respicio-Kingry LB; Davis JP; Schiffman E; Sloan LM; Schriefer ME; Replogle AJ; Paskewitz SM; Ray JA; Bjork J; Steward CR; Deedon A; Lee X; Kingry LC; Miller TK; Feist MA; Theel ES; Patel R; Irish CL; Petersen JM
    Lancet Infect Dis; 2016 May; 16(5):556-564. PubMed ID: 26856777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
    Preac-Mursic V; Weber K; Pfister HW; Wilske B; Gross B; Baumann A; Prokop J
    Infection; 1989; 17(6):355-9. PubMed ID: 2613324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
    Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
    [No Abstract]   [Full Text] [Related]  

  • 35. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Searching for Lyme borreliosis in Australia: results of a canine sentinel study.
    Irwin PJ; Robertson ID; Westman ME; Perkins M; Straubinger RK
    Parasit Vectors; 2017 Mar; 10(1):114. PubMed ID: 28285585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
    Shemenski J
    Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of Fas receptor and Fas ligand in the culture of the peripheral blood mononuclear cells stimulated with Borrelia burgdorferi sensu lato.
    Grygorczuk S; Osada J; Moniuszko A; Świerzbińska R; Kondrusik M; Zajkowska J; Dunaj J; Dąbrowska M; Pancewicz S
    Ticks Tick Borne Dis; 2015 Mar; 6(2):189-97. PubMed ID: 25541498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyme borreliosis.
    Hengge UR; Tannapfel A; Tyring SK; Erbel R; Arendt G; Ruzicka T
    Lancet Infect Dis; 2003 Aug; 3(8):489-500. PubMed ID: 12901891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lyme borreliosis: a European perspective on diagnosis and clinical management.
    Stanek G; Strle F
    Curr Opin Infect Dis; 2009 Oct; 22(5):450-4. PubMed ID: 19571749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.